期刊文献+

2型糖尿病病人血浆同型半胱氨酸水平与心脑血管并发症的关系 被引量:5

RELATIONSHIP BETWEEN HOMOCYSTEINE LEVEL AND INCIPIENT CARDIO-CEREBROVASCULAR COMPLICATION IN TYPE 2 DIABETES MELLITUS
下载PDF
导出
摘要 目的 探讨2型糖尿病(DM)并心、脑血管病变与血浆同型半胱氨酸(HCY)水平的关系.方法 用化学发光法测定49例2型DM病人及51例正常对照者血浆HCY水平.结果 2型DM病人无并发症组及有心、脑血管并发症组血浆HCY水平均较正常对照组明显升高,有心、脑血管并发症组较无并发症组升高,差异均有显著性(F=5.77,q=2.82~12.66,P〈0.05、0.01).高HCY血症组心、脑血管病的发生率较HCY正常组明显升高(χ^2=4.72,P〈0.05).结论 高HCY血症可能是DM病人易并发心、脑血管病的危险因素,早期给予干预治疗可能有助于延缓并发症的发生发展. Objective To investigate the relationship between the plasma homocysteine (HCY) level and incipient cardio-cerebrovascular complication in type 2 diabetes mellitus (DM). Methods Forw-nine patients with type 2 DM and 51 normal controls were involved in this study. The concentration of plasma HCY was examined by chemiluminescence technique. Results The concentration of HCY was significantly higher in type 2 DM with or without cardio-cerebrovascular complications than that in control subjects, and the plasma HCY level was higher in type 2 DM with cardio-cerebrovascular complications than in those without complications (F=5.77 ,q=2. 82-12. 66,P〈0. 05,0. 01). Diabetic patients with hyperhomocysteinmia had a higher incidence of cardio cerebrovascular complications compared with non hyperhomocysteinmia patients (χ^2 = 4. 72, P 〈 0.05 ). Conclusion Hyperhomocysteinmia may be a risk factor of cardio-cerebrovascular complication in type 2 DM. Early clinical intervention may delay the development of the complications.
出处 《齐鲁医学杂志》 2006年第3期245-246,共2页 Medical Journal of Qilu
关键词 半胱氨酸 糖尿病 2型 糖尿病血管病变 cysteine diabetes mellitus,type 2 diabetic angiopathies
  • 相关文献

参考文献9

二级参考文献27

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2Susan C, Louis M, Vivian F. Hyperhomocysteinemia-an emerging and important risk factor for thromboebolic and cardiovascular disease. Clin Chem, 1996,106:709-722
  • 3Jacob S, Paul FJ, Peter WF, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA, 1993,270:2693-2698.
  • 4Drzewoski J, Czupryniak L, Bud E. Total plasma homocysteine and insulin levels in type 2 diabetic patients with secondary failure to oral agents. Diabetes Care, 1999,22:2097-2103.
  • 5Lee WJ, Chen YT, Shen WH. Plasma homocysteine concentrations and insulin sensitivity in hypertensive subjects. Am J Hypertens, 2000,13(1 pt):14-20.
  • 6House JD, Jacobs RL, Stead LM, et al. Regulation of homocysteine metabolism. Adv Enzyme Regul, 1999,39:69-91.
  • 7Ueland P M, Refsum H. Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease and drug therapy. J Lab Clin Med,1989,114:437-501.
  • 8Lee H Y, Chae I H, Kim H S. Differential effects of homocysteine on porcine endothelial and vascular smooth muscle cells. J Cardiovasc Pharmacol, 2002,39:643-651.
  • 9Woo D K, Dudrick S J, Sumpio B E. Homocysteine stimulates MAP kinase in bovine aortic smooth muscle cells. Surgery,2000,128: 59- 66.
  • 10Chamley-Campbell J, Campbell G R, Ross R. Smooth muscle cell in culture,Physiol Rev, 1979,59: 1 -6.

共引文献106

同被引文献38

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部